Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Song

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Carcinogenesis|September 28, 2019
CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancerBaolong Wang, Jiqing Zheng, Qiongyuan Chen, et al.
Medicine|February 23, 2023
Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic reviewVikash Jaiswal, Nitya Batra, Mehak Dagar, et al.
Medicine|September 29, 2023
SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: A meta-analysis of randomised controlled trialsAkash Jaiswal, Vikash Jaiswal, Song Peng Ang, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
The Journal of Urology|May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive ValueMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology|June 24, 2025
Reply by AuthorsMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 17, 2026
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancerDeondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Carcinogenesis|September 28, 2019
CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancerBaolong Wang, Jiqing Zheng, Qiongyuan Chen, et al.
Medicine|February 23, 2023
Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic reviewVikash Jaiswal, Nitya Batra, Mehak Dagar, et al.
Medicine|September 29, 2023
SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: A meta-analysis of randomised controlled trialsAkash Jaiswal, Vikash Jaiswal, Song Peng Ang, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
The Journal of Urology|May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive ValueMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology|June 24, 2025
Reply by AuthorsMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 17, 2026
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancerDeondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 11